Patent Assignment
Reel/Frame 058348/0319
Assignment of Assignor's Interest
Recorded: 2021-12-09
Pages: 7
Assignors
GRIESSER, JAMES
Executed: 2021-06-28
DOBBINS, THOMAS W.
Executed: 2021-06-29
SEBREE, TERRI
Executed: 2021-10-26
Assignee
ZYNERBA PHARMACEUTICALS, INC.
80 W. LANCASTER AVENUE, SUITE 300, DEVON, PENNSYLVANIA, 19333
Covered Properties
(2)
Treatment of Fragile X Syndrome with Cannabidiol
Application:
17/360,781 →
Publication:
US 2021/0401769
Treatment of Fragile X Syndrome with Cannabidiol
Application:
63/045,664 →